KemPharm
在场
KemPharm 是一家在股票代码 KMPH (US) 下上市的公司。
高管
查看带有其 14 名主要高管的组织结构图
KemPharm 搜索最多的简介
- Travis Mickle, President, Chief Executive Officer and Director
- Joseph Saluri, Director
- Richard Pascoe, Executive Chairman of the Board
高管在KemPharm变化
- Nichol Ochsner已作为Vice President, Investor Relations and Corporate Communications加入公司 (新闻发布的2022八月9号).
创建提醒
跟踪 KemPharm 的高管变动
药店
KemPharm 拥有 1,995 家竞争者，其中包括 Johnson & Johnson (美国(美洲))、Pfizer (美国(美洲)) 和 Roche (瑞士)。
Popular M&A news in 药店
- Catalent Pharma Solutions 已收购 Metrics Contract Services (公布2022八月12号).
- CSL 已收购 Vifor Pharma (公布2022八月4号).
- PharmEasy 刚刚宣布为 200 筹款数百万美元。 (公布2022七月19号).
药店 行业的其他推荐联系人
消息
KemPharm 的最新新闻稿
- KemPharm to Report Second Quarter 2022 Financial Results | KemPharm
- KemPharm to Present at the Canaccord Genuity 42nd Annual Growth Conference | KemPharm
- KemPharm to Participate in the 2022 Joint NNPDF-INPDA Conference and Meeting | KemPharm
- KemPharm Announces Research Affirming Serdexmethylphenidate’s Lower Potential for Abuse Featured in Peer-Reviewed Publication, Current Medical Research & Opinion | KemPharm
- Press Releases | KemPharm
- KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline | KemPharm
- KemPharm Reports First Quarter 2022 Financial Results and Corporate Updates | KemPharm
- Press Releases | KemPharm
- KemPharm to Present at Multiple Upcoming Investor Conferences | KemPharm
- KemPharm Announces Submission of Investigational New Drug Application for Phase 2 Trial of KP1077 in Idiopathic Hypersomnia (IH) | KemPharm
- View more press releases Close
关于 KemPharm 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Travis Mickle 
